Your browser doesn't support javascript.
loading
Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) sponges microRNA-124-3p to up-regulate phosphodiesterase 4B (PDE4B) to accelerate the progression of Parkinson's disease.
Chen, Ming-Yu; Fan, Kai; Zhao, Lian-Jiang; Wei, Jie-Mei; Gao, Ji-Xu; Li, Zhen-Fu.
Afiliación
  • Chen MY; Department of Neurology, Linyi Central Hospital, Linyi City Shandong, China.
  • Fan K; Department of Neurology, The Third People's Hospital of Linyi, Linyi City Shandong, China.
  • Zhao LJ; Department of Neurology, The Third People's Hospital of Linyi, Linyi City Shandong, China.
  • Wei JM; Department of Neurology, Linyi Central Hospital, Linyi City Shandong, China.
  • Gao JX; Department of Laboratory, Linyi Cancer Hospital, Linyi City Shandong, China.
  • Li ZF; Department of Neurology, Linyi Central Hospital, Linyi City Shandong, China.
Bioengineered ; 12(1): 708-719, 2021 12.
Article en En | MEDLINE | ID: mdl-33522352
Reportedly, long non-coding RNA (lncRNA) are crucial modulators in neurodegenerative diseases. Herein, we investigated the role of lncRNA nuclear enriched abundant transcript 1 (NEAT1) in Parkinson's disease (PD). In-vitro PD model was established based on SH-SY5Y cells treated with 1-methyl-4-phenylpyridinium (MPP+). NEAT1, microRNA (miR) -124-3p and phosphodiesterase 4B (PDE4B) expression levels were examined by qRT-PCR. CCK-8 assay and LDH release assay were adopted to delve into the cell viability and cytotoxicity, respectively. Besides, western blot was utilized to determine mTOR, p-mTOR and PDE4B expression levels. ELISA was executed to detect the levels of tumor necrosis factor α (TNF-α), interleukin 1ß (IL-1ß) and interleukin 6 (IL-6). Dual-luciferase reporter assay and RIP assay were used to probe the relationship between miR-124-3p and NEAT1 or PDE4B. We demonstrated that, in SH-SY5Y cells treated with MPP+, NEAT1 and PDE4B expression levels were raised, while miR-124-3p expression was repressed; NEAT1 depletion or miR-124-3p overexpression increased the cell viability and suppressed cell injury. Besides, miR-124-3p was confirmed as the direct target of NEAT1, and its down-regulation counteracted the impact of NEAT1 depletion on SH-SY5Y cells. PDE4B was as the downstream target of miR-124-3p, and its overexpression weakens the impact of miR-124-3p on SH-SY5Y cells. Additionally, NEAT1 decoyed miR-124-3p to modulate PDE4B expression. Collectively, in MPP+-induced SH-SY5Y cells, NEAT1 depletion increases cell viability, represses cytotoxicity and reduces inflammatory response by regulating miR-124-3p and PDE4B expression levels, suggesting that NEAT1 may be a promising target for treating PD.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Fosfodiesterasas de Nucleótidos Cíclicos Tipo 4 / ARN Largo no Codificante Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Bioengineered Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Fosfodiesterasas de Nucleótidos Cíclicos Tipo 4 / ARN Largo no Codificante Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Bioengineered Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos